News/Columns

Appeals Court Stays Injunction in Sanofi-Amgen Patent Fight

, The National Law Journal

   | 0 Comments

The U.S. Court of Appeals for the Federal Circuit hit pause Wednesday on a Delaware judge's order that would block sales of Sanofi's cholesterol drug Praluent.

This premium content is reserved for Delaware Law Weekly subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202778796118

Thank you!

This article's comments will be reviewed.